HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrzej J Bojarski Selected Research

serotonin 6 receptor

10/2021Neuropathic pain-alleviating activity of novel 5-HT6 receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamide.
1/2021Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties.
10/2020mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment.
1/2016Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrzej J Bojarski Research Topics

Disease

7Schizophrenia (Dementia Praecox)
01/2023 - 01/2014
6Alzheimer Disease (Alzheimer's Disease)
05/2023 - 01/2016
5Neuralgia (Stump Neuralgia)
04/2023 - 05/2019
4Pain (Aches)
10/2023 - 12/2020
4Mental Disorders (Mental Disorder)
09/2023 - 01/2018
4Neurodegenerative Diseases (Neurodegenerative Disease)
04/2023 - 01/2019
4Neoplasms (Cancer)
04/2023 - 06/2017
4Neurobehavioral Manifestations
01/2023 - 01/2014
4Memory Disorders (Memory Loss)
12/2020 - 01/2016
3Cognitive Dysfunction
10/2019 - 01/2016
3Prostatic Neoplasms (Prostate Cancer)
10/2018 - 06/2017
2Mood Disorders (Mood Disorder)
04/2023 - 10/2013
2Psychotic Disorders (Schizoaffective Disorder)
03/2022 - 07/2021
2Hyperalgesia
10/2021 - 10/2020
2Central Nervous System Diseases (CNS Diseases)
01/2021 - 07/2015
2Seizures (Absence Seizure)
03/2016 - 01/2012
1Wounds and Injuries (Trauma)
04/2024
1Anhedonia
09/2023
1Frontotemporal Dementia (Semantic Dementia)
05/2023
1Tauopathies
05/2023
1Inflammation (Inflammations)
04/2023
1Ischemia
04/2023
1Leukemia
04/2023
1Rheumatoid Arthritis
04/2023
1Osteoarthritis
04/2023
1Sleep Wake Disorders
01/2022
1Chronobiology Disorders (Circadian Rhythm Disorder)
01/2022
1Ebola Hemorrhagic Fever
03/2021
1Chronic Pain
12/2020
1Cardiotoxicity
12/2020
1Acute Pain
12/2020
1Peripheral Nervous System Diseases (PNS Diseases)
10/2020
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
12/2019
1Opioid-Related Disorders (Opiate Addiction)
12/2019
1Neuroblastoma
10/2018

Drug/Important Bio-Agent (IBA)

10LigandsIBA
01/2023 - 10/2018
8Serotonin (5 Hydroxytryptamine)IBA
03/2022 - 01/2012
4Antipsychotic Agents (Antipsychotics)IBA
01/2023 - 01/2014
4serotonin 6 receptorIBA
10/2021 - 01/2016
3Analgesics (Analgesic Drugs)IBA
01/2023 - 05/2019
3Dopamine (Intropin)FDA LinkGeneric
03/2022 - 07/2015
3Serotonin ReceptorsIBA
03/2022 - 10/2018
3Scopolamine (Hyoscine)FDA Link
12/2020 - 01/2018
2Opioid Analgesics (Opioids)IBA
10/2023 - 12/2020
2serotonin 7 receptorIBA
01/2022 - 05/2019
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2021 - 01/2019
25-HT1A Serotonin ReceptorIBA
01/2021 - 10/2018
2Glycogen Synthase Kinase 3IBA
01/2021 - 01/2019
2quinolineIBA
01/2019 - 01/2016
2Phencyclidine (Angel Dust)IBA
01/2018 - 01/2016
2Antidepressive Agents (Antidepressants)IBA
06/2017 - 10/2013
23- benzenesulfonyl- 8- piperazin- 1- ylquinolineIBA
06/2016 - 01/2016
1Diclofenac (SR 38)FDA LinkGeneric
04/2024
1Hallucinogens (Psychedelics)IBA
09/2023
1Psilocybin (Psilocibin)IBA
09/2023
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
05/2023
1Amisulpride (Solian)IBA
05/2023
1CytokinesIBA
04/2023
1CationsIBA
04/2023
1Purinergic P2X7 ReceptorsIBA
04/2023
1Adenosine Triphosphate (ATP)IBA
04/2023
14-hydroxyquinazolineIBA
01/2023
1piperidineIBA
01/2023
1Sigma-1 ReceptorIBA
01/2023
1Histamine (Histamine Dihydrochloride)FDA Link
01/2023
1Monoamine Oxidase (MAO)IBA
06/2022
1Amphetamine (Amfetamine)FDA LinkGeneric
03/2022
1N-dodecyl-L-lysine amideIBA
03/2022
1cariprazineIBA
03/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2022
1ArrestinIBA
01/2022
1Phosphotransferases (Kinase)IBA
10/2021
1BenzimidazolesIBA
03/2021
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
01/2021
1Ondansetron (Zofran)FDA LinkGeneric
01/2021
1Formaldehyde (Formol)FDA Link
12/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2020
1Cell-Penetrating PeptidesIBA
10/2020
1Naloxone (Narcan)FDA LinkGeneric
12/2019
1Morphine (MS Contin)FDA LinkGeneric
12/2019
1naphthaleneIBA
10/2019
1AminesIBA
10/2019
1Glycine Plasma Membrane Transport ProteinsIBA
01/2019
1Dopamine Agents (Dopaminergic Agents)IBA
01/2019
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2019
1Glutamic Acid (Glutamate)FDA Link
01/2019
1gamma-Aminobutyric Acid (GABA)IBA
01/2019
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2019
1Dopamine D3 ReceptorsIBA
01/2019
1pyrrolidineIBA
01/2019
1Dopamine D2 Receptor AntagonistsIBA
01/2019
1AndrogensIBA
10/2018
1hydroxide ionIBA
10/2018
1benzamideIBA
10/2018
1Fluoxetine (Prozac)FDA LinkGeneric
10/2018
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
10/2018

Therapy/Procedure

4Therapeutics
09/2023 - 12/2020
2Drug Therapy (Chemotherapy)
04/2023 - 01/2012
1Analgesia
10/2023
1Ligation
10/2021